Biomarkers for liver fibrosis

A method of diagnosing or prognosing liver fibrosis in a subject comprising:

• detecting at least two, at least 3, or at least 4 liver fibrosis-related molecules listed in any of Tables 1, 2, 3, 5, 6 and 12 and any of SEQ ID NOS:
• 1-5544 in a sample obtained from the subject;
• comparing expression of the at least two liver fibrosis-related molecules to controls representing expression of the at least two liver fibrosis-related molecules expected in a subject who does not have liver fibrosis;
• and
• diagnosing or prognosing liver fibrosis in the subject when differential expression of the at least two liver fibrosis-related molecules between the sample and the control is detected, wherein differential expression comprises an increase or decrease of at least 10% relative to the controls.